Trial Profile
First-in-human pilot study of Mul-1867-CF in Cystic Fibrosis patients during pulmonary exacerbation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2015
Price :
$35
*
At a glance
- Drugs MUL 1867 (Primary)
- Indications Cystic fibrosis
- Focus First in man; Therapeutic Use
- 02 Nov 2015 New trial record
- 01 Nov 2014 Positive results published in TGV-Therapeutics media release.